KEGG: vpa:VPA1414
STRING: 223926.VPA1414
UPF0267 protein VPA1414 is a recombinant protein that can be expressed in multiple host systems. According to research data, E. coli and yeast expression systems provide the best yields and shorter turnaround times for this protein, making them particularly suitable for initial characterization studies and applications where post-translational modifications are not critical . The "UPF" designation indicates it belongs to an uncharacterized protein family whose complete functions have yet to be fully determined through structural and functional analyses.
Researchers should opt for insect cells with baculovirus or mammalian cell expression systems when studying VPA1414 in contexts where posttranslational modifications are necessary for correct protein folding or maintenance of biological activity . While these systems typically yield less protein and require longer production times compared to prokaryotic systems, they provide the eukaryotic cellular machinery needed for complex modifications that may be essential for certain experimental applications, particularly those investigating the protein's native structural conformations or functional interactions.
For optimal stability of recombinant proteins like VPA1414, long-term storage should be at -20°C or -80°C, with working aliquots maintained at 4°C for up to one week to minimize degradation . Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of activity. When preparing aliquots, researchers should consider buffer composition, including appropriate stabilizers such as glycerol or specific salt concentrations that maintain protein integrity during the freeze-thaw process.
To optimize E. coli expression of VPA1414, researchers should implement a systematic optimization strategy that includes:
| Optimization Parameter | Methodological Approach | Expected Impact |
|---|---|---|
| Strain selection | Test BL21(DE3), Rosetta, OrigamiB strains | Addresses codon bias and disulfide bond formation |
| Induction conditions | Vary IPTG (0.1-1.0 mM), temperature (16-37°C), time (2-24h) | Balances yield vs. solubility |
| Media composition | Compare LB, TB, auto-induction media | Affects cell density and protein yield |
| Co-expression strategies | Add chaperones (GroEL/ES, DnaK) | Improves folding and solubility |
| Fusion tags | Test His, GST, MBP, SUMO tags | Enhances solubility and facilitates purification |
The optimization process should begin with small-scale expression trials that systematically test these variables before scaling up to larger production volumes for final purification.
The purification strategy for VPA1414 should be tailored to the expression system used and the presence of affinity tags. General recommendations include:
For E. coli and yeast expressions: A two-step approach beginning with affinity chromatography (IMAC for His-tagged constructs) followed by size exclusion chromatography (SEC) typically achieves >90% purity .
For insect and mammalian expressions: More complex purification schemes may be necessary, potentially incorporating ion exchange chromatography between the affinity and size exclusion steps to remove host cell proteins that may interact with the target protein through post-translational modifications.
For tag-free preparations: Consider using specialized proteases (TEV, PreScission) for tag removal followed by negative affinity chromatography and polishing with SEC.
Quality assessment of purified VPA1414 should include multiple analytical techniques:
| Analytical Method | Application | Critical Parameters |
|---|---|---|
| SDS-PAGE | Purity assessment | ≥95% purity by densitometry |
| Western blot | Identity confirmation | Specific antibody reactivity |
| Mass spectrometry | Molecular weight verification | Within 0.1% of theoretical mass |
| Size exclusion chromatography | Aggregation analysis | ≥90% monomeric species |
| Circular dichroism | Secondary structure evaluation | Consistent spectral characteristics |
| Dynamic light scattering | Solution homogeneity | Polydispersity index <0.2 |
| Functional assays | Activity confirmation | Activity comparable to standards |
These methods collectively provide a comprehensive profile of the protein's physical and functional characteristics, ensuring reliable experimental outcomes.
Recent advancements in nanopore technology offer promising approaches for analyzing VPA1414's structural characteristics. Researchers have developed methods for long-range, single-molecule sequencing of intact protein strands using Oxford Nanopore Technologies' MinIon device . This methodology involves:
Transporting the protein substrate through a nanopore via electrophoretic force
Using a blocking domain affixed to the C-terminal to prevent complete translocation
Adding ClpX (an ATP-powered protein unfoldase) to pull the analyte back through the pore in a controlled fashion
This technique could provide valuable insights into VPA1414's structural features that traditional sequencing methods might miss, particularly for identifying long-range interactions and conformational states.
When designing panel data experiments to investigate VPA1414 function across multiple conditions or time points, researchers should:
Account for arbitrary error structures and non-constant serial correlation in experimental design to avoid incorrectly powered experiments
Implement "serial-correlation-robust" power calculations to achieve properly powered experiments that can detect statistically significant effects
Consider variance components when determining sample sizes and replicate numbers
Apply appropriate statistical models that account for the specific error structure of the experimental data
These statistical considerations are crucial for ensuring that experiments investigating VPA1414 function yield reliable and reproducible results.
To investigate VPA1414's potential interaction partners, researchers should employ a multi-faceted approach:
| Interaction Analysis Method | Strength | Limitation |
|---|---|---|
| Yeast two-hybrid screening | Identifies direct binary interactions | May yield false positives/negatives |
| Co-immunoprecipitation | Detects interactions in native conditions | Requires specific antibodies |
| Proximity labeling (BioID, APEX) | Identifies proximal proteins in live cells | May label nearby non-interacting proteins |
| Surface plasmon resonance | Provides binding kinetics | Requires purified proteins |
| Crosslinking mass spectrometry | Maps interaction interfaces | Complex data analysis |
| Fluorescence resonance energy transfer | Measures interactions in live cells | Requires fluorescent protein fusions |
A combination of these methods provides the most comprehensive analysis of VPA1414's interactome and potential functional roles in cellular processes.
To study VPA1414 in cellular trafficking contexts, researchers can adapt approaches used for other trafficking proteins such as VPS proteins:
Generate fluorescently tagged VPA1414 constructs to track localization and movement through cellular compartments using live-cell imaging
Perform co-localization studies with established markers of various cellular compartments (early/late endosomes, Golgi, lysosomes) to determine its subcellular distribution
Conduct pulse-chase experiments to track the protein's movement through trafficking pathways
Use temperature blocks or chemical inhibitors of specific trafficking steps to determine where VPA1414 functions in the pathway
Understanding VPA1414's role in trafficking may provide insights into its cellular function and potential involvement in disease processes.
Given that VPA1414 can be expressed in systems capable of post-translational modifications , researchers should employ these analytical approaches:
Mass spectrometry analysis (LC-MS/MS) with enrichment strategies specific for phosphorylation, glycosylation, or other modifications
Western blotting with modification-specific antibodies (e.g., anti-phospho, anti-ubiquitin)
Mobility shift assays to detect changes in electrophoretic mobility due to modifications
Site-directed mutagenesis of predicted modification sites to assess functional consequences
Comparison of protein expressed in different systems (E. coli vs. mammalian cells) to identify modification-dependent properties
These approaches can reveal how post-translational modifications affect VPA1414's structure, localization, and function in different cellular contexts.
When encountering solubility or stability issues with VPA1414, researchers should implement this systematic troubleshooting approach:
| Challenge | Strategy | Implementation |
|---|---|---|
| Poor solubility | Optimize buffer conditions | Test pH range (6.0-8.5), salt concentrations (100-500 mM), and additives (glycerol, arginine, detergents) |
| Precipitation during concentration | Adjust concentration method | Reduce centrifugal force, use dialysis or diafiltration instead of centrifugal concentrators |
| Degradation during purification | Enhance protease protection | Add protease inhibitor cocktail, reduce purification time, maintain samples at 4°C |
| Aggregation during storage | Optimize storage conditions | Add stabilizers (10% glycerol, 1 mM DTT), aliquot to avoid freeze-thaw cycles |
| Loss of activity | Preserve functional elements | Include cofactors or binding partners, optimize buffer for activity maintenance |
These approaches should be implemented systematically with appropriate controls to identify the most effective conditions for maintaining VPA1414 integrity.
To ensure batch-to-batch consistency in VPA1414 expression:
Standardize seed culture conditions (media, growth phase, passage number)
Use consistent induction parameters (OD600 at induction, inducer concentration, temperature)
Implement rigorous quality control metrics for each purification step
Maintain detailed records of expression conditions and yields
Pool multiple small-scale expressions rather than single large-scale batches when consistency is critical
Additionally, researchers should consider implementing a reference standard system where each new batch is compared to a well-characterized reference batch using multiple analytical techniques to ensure functional equivalence.